Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Pleased to share our new publication in Research and Practice in Thrombosis and Haemostasis:
‘Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry.’
In this RIETE Registry analysis of 1,186 patients with VTE receiving retrievable IVC filters, filter retention was associated with worse outcomes compared with filter removal.
Key findings:
- Higher VTE recurrence with retained filters: 7.5 percent versus 1.8 percent
- Recurrences were mainly driven by DVT.
- Filter removal was associated with lower adjusted risk of VTE recurrence
- All-cause mortality was higher in patients with retained filters: 17.0 percent versus 6.3 percent
- Major bleeding remained infrequent and was not significantly different between groups.
Clinical message: retrievable IVC filters require structured follow-up and timely removal whenever clinically feasible.
Grateful to Omri Cohen, Manuel Monreal, the RIETE investigators, and all co-authors for the collaboration.
The accompanying image was AI-generated – with supervision – to present the study on LinkedIn.”
Title: Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry
Authors: Omri Cohen, Davide Santagata, Gili Kenet, Juan José López-Núñez, My Hanh Bui, Andris Skride, Patricia López-Miguel, Raimundo Tirado, Fernando Arméstar, Manuel Monreal

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria